Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.
about
COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.Role of prostacyclin in pulmonary hypertension.Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway.Vascular dysfunction in the stroke-prone spontaneously hypertensive rat is dependent on constrictor prostanoid activity and Y chromosome lineage.
P2860
Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@en
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@nl
type
label
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@en
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@nl
prefLabel
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@en
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@nl
P2093
P2860
P50
P356
P1433
P1476
Aspirin-triggered 15-epi-lipox ...... lications for a clinical test.
@en
P2093
Elaine Holmes
Jane A Mitchell
Karen A Massey
Martina H Lundberg
Nicholas S Kirkby
William M B Edmands
P2860
P304
P356
10.1096/FJ.12-215533
P407
P577
2013-06-21T00:00:00Z